We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Changes in peritoneal membrane permeability and proteinuria in patients on peritoneal dialysis after treatment with paricalcitol − a preliminary study.
- Authors
Coronel, Francisco; Cigarran, Secundino; Gomis, Antonio; Rodríguez-Cubillo, Beatriz; Herrero, José Antonio; Delgado, Pablo; Delgado, Jesus
- Abstract
Patients on peritoneal dialysis (PD) have protein loss through peritoneal membrane (PM) and experience changes in permeability of the membrane. Paricalcitol is a selective vitamin D receptor activator with an effect upon systemic inflammation and an inhibitory effect upon the renin-angiotensin-aldosterone system (RAAS).
- Publication
Clinical nephrology, 2012, Vol 78, Issue 2, p93
- ISSN
0301-0430
- Publication type
Journal Article
- DOI
10.5414/CN107570